Amgen

YTD

ALL

Trade Amgen 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About AMGN

Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture, and marketing of human therapeutics. The company was founded by William K.

CEO

Robert A. Bradway

CEORobert A. Bradway

Employees

28,000

Employees28,000

Headquarters

Thousand Oaks, California

HeadquartersThousand Oaks, California

Founded

1980

Founded1980

Employees

28,000

Employees28,000

AMGN Key Statistics

Market cap

146.07B

Market cap146.07B

Price-Earnings ratio

23.94

Price-Earnings ratio23.94

Dividend yield

3.48%

Dividend yield3.48%

Average volume

3.47M

Average volume3.47M

High today

$271.98

High today$271.98

Low today

$264.15

Low today$264.15

Open price

$265.06

Open price$265.06

Volume

3.99M

Volume3.99M

52 Week high

$346.85

52 Week high$346.85

52 Week low

$253.30

52 Week low$253.30

AMGN News

Benzinga 11h

Stock Of The Day: Amgen Slips With Healthcare Sector, But Signals Point To A Reversal

The stock of Amgen Inc. AMGN is trading higher on Thursday. But along with the rest of the healthcare sector, it is still in a steep downtrend. The news regardi...

TipRanks 3d

Amgen Stock May Get Fatter Premiums As It Slims Down Obesity Drug Competition with MariTide

Amgen (AMGN) is diving headfirst into the booming obesity drug market. The company’s latest venture focuses on MariTide, a promising weight loss injection. This...

Analyst ratings

47%

of 32 ratings

Buy

43.8%

Hold

46.9%

Sell

9.4%

People also own

Based on the portfolios of people who own AMGN. This list is generated using Robinhood data, and it’s not a recommendation.